SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the United States commercial launch of its new Tandem ...

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today presented new real-world insights from a survey on Tandem Mobi ...

Users of Tandem Diabetes Care’s insulin pumps now have a new way to monitor the pumps’ data and manage their equipment. After being unveiled during the American Diabetes Association’s annual ...

Tandem Diabetes Care, Inc. TNDM is well-poised for growth in the coming quarters, backed by its impressive lineup of new products. The flourishing diabetes market provides a favorable opportunity for ...

Tandem Diabetes Care (NASDAQ:TNDM) is set to give its latest quarterly earnings report on Wednesday, 2025-04-30. Here's what investors need to know before the announcement. Analysts estimate that ...

Product Portfolio and Technology Tandem’s strategy centers on offering patients choice through its dual-platform approach, featuring the t:slim X2 insulin pump and the newer Tandem Mobi system. Both ...

Tandem Diabetes Care (NASDAQ: TNDM) presented its company overview on August 6, 2025, highlighting its position in the diabetes technology market and strategic initiatives. The presentation comes as ...